Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Cell Viability Assay Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the cell viability assay market looks promising with opportunities in academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and diagnostic laboratories. The global cell viability assay market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing cell-based assay research & development and rising incidence and prevalence of chronic and infectious diseases. 

A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global cell viability assay market report, please download the report brochure.
 
 

 
 
In this market, consumables is the largest product of cell viability assay, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the cell viability assay market are given below:
 


 



The study includes trends and forecast for the global cell viability assay market by product, application, end user, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Consumables  
  • Instruments  
 
By Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Basic Research 
  • Stem Cell Research 
  • Drug Discovery & Development 
  • Clinical & Diagnostic Applications 
  • Other Applications  

By End User [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Academic and Research Institutes 
  • Pharmaceutical and Biotechnology Companies 
  • Hospitals and Diagnostic Laboratories 
  • Other End Users 

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil

Some of the cell viability assay model companies profiled in this report include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck, GE Healthcare, Danher, Abcam, BioTek Instruments, PerkinElmer, and Promega Corporation.

Lucintel forecasts that consumbales will remain the largest product segment over the forecast period due to growing investments by government bodies and private sector organizations in research activities that are focused on developing new treatments for various human diseases.

Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to the increasing number of R&D activities undertaken by these companies for the development of biopharmaceutical products.

North America will remain the largest region over the forecast period due to growing incidences of various infectious diseases, investment initiatives by governments, and the high-quality infrastructure for clinical and laboratory research in the region. 




 
Features of the Global Cell Viability Assay Market
 
  • Market Size Estimates: Global cell viability assay market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global cell viability assay market size by various segments, such as product, application, and end user in terms of value.
  • Regional Analysis: Global cell viability assay market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, application, end user, and region for the global cell viability assay market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global cell viability assay market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.



 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global cell viability assay market by product (consumables and instruments), application (basic research, stem cell research, drug discovery & development, clinical & diagnostic applications, and other applications), end user (academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global cell viability assay market?
Q.5 What are the business risks and threats to the global cell viability assay market?
Q.6 What are the emerging trends in this cell viability assay market and the reasons behind them?
Q.7 What are some changing demands of customers in this cell viability assay market?
Q.8 What are the new developments in this cell viability assay market? Which companies are leading these developments?
Q.9 Who are the major players in this cell viability assay market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this cell viability assay market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global cell viability assay market?

 



Report Scope



Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)		 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Consumables and Instruments), Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications), and End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost

Table of Contents


1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Cell Viability Assay Market Trends and Forecast
3.3: Global Cell Viability Assay Market by Product
3.3.1: Consumables
3.3.2: Instruments
3.4: Global Cell Viability Assay Market by Application
3.4.1: Basic Research  
3.4.2: Stem Cell Research
3.4.3: Drug Discovery & Development 
3.4.4: Clinical & Diagnostic Applications 
3.4.5: Other Applications 
3.5: Global Cell Viability Assay Market by End User
3.5.1: Academic and Research Institutes 
3.5.2: Pharmaceutical and Biotechnology Companies   
3.5.3: Hospitals and Diagnostic Laboratories  
3.5.4: Other End Users  

4. Market Trends and Forecast Analysis by Region
4.1: Global Cell Viability Assay Market by Region
4.2: North American Cell Viability Assay Market
4.2.1: Market by Product: Consumables and Instruments
4.2.2: Market by Application: Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications
4.2.3: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users 
4.2.4: The United States Cell Viability Assay Market
4.2.5: The Canadian Cell Viability Assay Market
4.2.6: The Mexican Cell Viability Assays Market
4.3: European Cell Viability Assay Market
4.3.1: Market by Product: Consumables and Instruments
4.3.2: Market by Application: Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications
4.3.3: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users 
4.3.4: The United Kingdom Cell Viability Assay Market
4.3.5: The Spanish Cell Viability Assay Market
4.3.6: The German Cell Viability Assay Market
4.3.7: The French Cell Viability Assay Market
4.4: APAC Cell Viability Assays Market
4.4.1: Market by Product: Consumables and Instruments
4.4.2: Market by Application: Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications
4.4.3: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users 
4.4.4: The Chinese Cell Viability Assay Market
4.4.5: The Indian Cell Viability Assay Market
4.4.6: The Japanese Cell Viability Assay Market
4.5: ROW Cell Viability Assay Market
4.5.1: Market by Product: Consumables and Instruments
4.5.2: Market by Application: Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications
4.5.3: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users 
4.5.4: Brazilian Cell Viability Assay Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Cell Viability Assay Market by Product
7.1.2: Growth Opportunities for the Global Cell Viability Assay Market by Application
7.1.3: Growth Opportunities for the Global Cell Viability Assay Market by End User
7.1.4: Growth Opportunities for the Global Cell Viability Assay Market by Region
7.2: Emerging Trends in the Global Cell Viability Assay Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Cell Viability Assay Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Viability Assay  Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: Thermo Fisher Scientific 
8.2: Bio-Rad Laboratories 
8.3: Merck 
8.4: GE Healthcare 
8.5: BioTek Instruments  
8.6: PerkinElmer 
8.7: Abcam
8.8: Promega Corporation 
8.9: Danaher Corporation 
8.10: Becton, Dickinson and Company 
 
.

Buy full report or by chapter as follows

Limited Time Offer

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Cell Viability Assay Market: Trends, Forecast and Competitive Analysis Full Report $ 2,990
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Cell Viability Assay Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on